Pfizer Inc. said late Wednesday that the Food and Drug Administration approved its respiratory syncytial virus vaccine Abrysvo for older adults. The drug...
Pfizer Inc. PFE said late Wednesday that the Food and Drug Administration approved its respiratory syncytial virus vaccine Abrysvo for older adults. The drug maker said the FDA approved Abrysvo for use in adults 60 years of age or older. RSV is a contagious virus that attacks the lungs and breathing passages, and is considered a common cause of respiratory illness globally, Pfizer said, adding the vaccine will be available in the third quarter before RSV season in the fall.
PFE said late Wednesday that the Food and Drug Administration approved its respiratory syncytial virus vaccine Abrysvo for older adults. The drug maker said the FDA approved Abrysvo for use in adults 60 years of age or older. RSV is a contagious virus that attacks the lungs and breathing passages, and is considered a common cause of respiratory illness globally, Pfizer said, adding the vaccine will be available in the third quarter before RSV season in the fall.
Indonesia Berita Terbaru, Indonesia Berita utama
Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.
FDA issues warning about some compounded versions of semaglutide for diabetes, weight loss | CNNThe US Food and Drug Administration issued a warning Tuesday about compounded versions of the drug semaglutide, which is approved for treatment of diabetes and excess weight.
Baca lebih lajut »
When courts challenge the FDA’s authority, they put patients’ lives at riskThe entire biotechnology and pharmaceutical industry will be thrown into turmoil if judges can second-guess the scientific expertise of the US Food and Drug Administration.
Baca lebih lajut »
‘Exciting Time’: FDA Commissioner Talks AI and MisinformationShould we be worried about AI's growing influence in healthcare, and what can the FDA do about the Adderall shortage? WebMD Chief Medical Officer drjohnwhyte sat down with US_FDA Commissioner Dr. Robert M. Califf to talk about this and more. Watch here:
Baca lebih lajut »
FDA warns about compounded versions of popular weight loss drugsFederal health officials say some medications being sold may not contain the same active ingredient as FDA-approved semaglutide products.
Baca lebih lajut »
Change Makers: FDA Commissioner Dr Califf on Public Health📢 Don't miss the exclusive interview with DrCaliff_FDA, conducted by drjohnwhyte! They discuss vital topics: misinformation, drug shortages, marijuana regulation, obesity, and AI in drug review. Tune in! MedNews Healthcare
Baca lebih lajut »
Ozempic Craze Has Spawned a Sketchy Black Market, FDA WarnsThe FDA has received adverse event reports from people using compounded semaglutide, which might not contain the same version of the popular obesity drug.
Baca lebih lajut »